Tower Research Capital LLC (Trc) Emergent Bio Solutions Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,403 shares of EBS stock, worth $106,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,403
Previous 16,576
1.04%
Holding current value
$106,619
Previous $158,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding EBS
# of Institutions
179Shares Held
38.2MCall Options Held
128KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$20.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$16.3 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$14.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$11.1 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $324M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...